{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:20:09Z","timestamp":1790508009118,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    The reactive oxygen species (ROS)-generating enzyme NOX3 has recently been implicated in the pathophysiology of several acquired forms of sensorineural hearing loss, including cisplatin-, noise- and age-related hearing loss. NOX3 is highly and specifically expressed in the inner ear and therefore represents an attractive target for specific intervention aiming at otoprotection. Despite the strong rationale to inhibit NOX3, there is currently no specific pharmacological inhibitor available. Molecular therapy may represent a powerful alternative. In this study, we developed and tested a collection of small interfering (si) RNA constructs to establish a proof of concept of NOX3 inhibition through local delivery in the mouse inner ear. The inhibitory potential of 10 different siRNA constructs was first assessed in three different cells lines expressing the NOX3 complex. Efficacy of the most promising siRNA construct to knock-down NOX3 was then further assessed\n                    <jats:italic>in vivo<\/jats:italic>\n                    , comparing middle ear delivery and direct intracochlear delivery through the posterior semi-circular canal. While hearing was completely preserved through the intervention, a significant downregulation of NOX3 expression in the mouse inner ear and particularly in the spiral ganglion area at clinically relevant levels (&amp;gt;60%) was observed 48 h after treatment. In contrast to successful intracochlear delivery, middle ear administration of siRNA failed to significantly inhibit Nox3 mRNA expression. In conclusion, intracochlear delivery of NOX3-siRNAs induces a robust temporal NOX3 downregulation, which could be of relevance to prevent predictable acute insults such as cisplatin chemotherapy-mediated ototoxicity and other forms of acquired hearing loss, including post-prevention of noise-induced hearing loss immediately after trauma. Successful translation of our concept into an eventual clinical use in humans will depend on the development of atraumatic and efficient delivery routes into the cochlea without a risk to induce hearing loss through the intervention.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2022.993017","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T05:55:23Z","timestamp":1663307723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Development and in vivo validation of small interfering RNAs targeting NOX3 to prevent sensorineural hearing loss"],"prefix":"10.3389","volume":"13","author":[{"given":"German","family":"Nacher-Soler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Marteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Barenzung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Sgroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Senn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/rej.2014.1637","article-title":"Cognitive frailty: a systematic review of epidemiological and neurobiological evidence of an age-related clinical condition","volume":"18","author":"Panza","year":"2015","journal-title":"Rejuvenation Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nrneurol.2015.12","article-title":"Age-related hearing impairment-a risk factor and frailty marker for dementia and AD","volume":"11","author":"Panza","year":"2015","journal-title":"Nat Rev Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1176\/appi.ajp.2017.17040423","article-title":"Sensation and psychiatry: linking age-related hearing loss to late-life depression and cognitive decline","volume":"175","author":"Rutherford","year":"2018","journal-title":"Am J Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"680856","DOI":"10.3389\/fnins.2021.680856","article-title":"Age-related changes in the cochlea and vestibule: shared patterns and processes","volume":"15","author":"Paplou","year":"2021","journal-title":"Front Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"14077","DOI":"10.1523\/JNEUROSCI.2845-09.2009","article-title":"Adding insult to injury: cochlear nerve degeneration after \u201ctemporary\u201d noise-induced hearing loss","volume":"29","author":"Kujawa","year":"2009","journal-title":"J Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.2174\/1381612821666151029112421","article-title":"NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES","volume":"21","author":"Rousset","year":"2015","journal-title":"Curr Pharm Des."},{"key":"B7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.07.046","article-title":"Nox family NADPH oxidases: molecular mechanisms of activation","volume":"76","author":"Brandes","year":"2014","journal-title":"Free Radic Biol Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.redox.2017.05.007","article-title":"Corrigendum to \u201cEuropean contribution to the study of ROS: a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)","volume":"13","author":"Egea","year":"2017"},{"key":"B9","doi-asserted-by":"publisher","first-page":"46065","DOI":"10.1074\/jbc.M403046200","article-title":"NOX3, a superoxide-generating NADPH oxidase of the inner ear","volume":"279","author":"B\u00e1nfi","year":"2004","journal-title":"J Biol Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1101\/gad.1172504","article-title":"Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase","volume":"18","author":"Paffenholz","year":"2004","journal-title":"Genes Dev."},{"key":"B11","first-page":"S28","article-title":"Tissue distribution and putative physiological function of NOX family NADPH oxidases","volume":"57","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1523\/JNEUROSCI.2672-20.2021","article-title":"Nox3-derived superoxide in cochleae induces sensorineural hearing loss","volume":"41","author":"Mohri","year":"2021","journal-title":"J Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/ars.2010.3110","article-title":"Transtympanic administration of Short Interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat","volume":"13","author":"Mukherjea","year":"2010","journal-title":"Antioxid Redox Signal."},{"key":"B14","article-title":"Redox activation of excitatory pathways in auditory neurons as mechanism of age-related hearing loss","volume-title":"Redox Biol 30.","author":"Mohri","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","first-page":"832314","DOI":"10.3389\/fcell.2022.832314","article-title":"NADPH oxidase 3 deficiency protects from noise-induced sensorineural hearing loss","volume":"10","author":"Rousset","year":"2022","journal-title":"Front Cell Dev Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1152\/physrev.00053.2017","article-title":"Toward cochlear therapies","volume":"98","author":"Wang","year":"2018","journal-title":"Physiol Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrd4533","article-title":"New treatment options for hearing loss","volume":"14","author":"Muller","year":"2015","journal-title":"Nat Rev Drug Discov."},{"key":"B18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12551-017-0392-1","article-title":"Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer","volume":"10","author":"Ahmadzada","year":"2018","journal-title":"Biophys Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/nano7040077","article-title":"siRNA delivery strategies: a comprehensive review of recent developments","volume":"7","author":"Tatiparti","year":"2017","journal-title":"Nanomaterials."},{"key":"B20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/AUD.0b013e3181c351f2","article-title":"Drug delivery for treatment of inner ear disease: current state of knowledge","volume":"31","author":"McCall","year":"2010","journal-title":"Ear Hear."},{"key":"B21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-1-4939-3615-1_21","article-title":"An overview of nanoparticle based delivery for treatment of inner ear disorders","volume":"1427","author":"Pyykko","year":"2016","journal-title":"Methods Mol Biol."},{"key":"B22","unstructured":"Concentration of viral vectors by co-precipitation with calcium phosphate18894\n            PhamL\n            YeH\n            CossetFL\n            RussellSJ\n            PengKW\n          11318118J Gene Med.32001"},{"key":"B23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fncel.2021.701783","article-title":"Local cisplatin delivery in mouse reliably models sensorineural ototoxicity without systemic side effects","volume":"15","author":"Nacher-Soler","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep46827","article-title":"Corrigendum: cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction","volume":"7","author":"Suzuki","year":"2017","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1109\/MC.1983.1654163","article-title":"Sternberg. Biomedical image processing","volume":"16","year":"1983","journal-title":"Computer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"Ilastik: interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat Methods."},{"key":"B27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.heares.2015.03.008","article-title":"High quality RNA extraction of the mammalian cochlea for qRT-PCR and transcriptome analyses","volume":"325","author":"Vikhe Patil","year":"2015","journal-title":"Hear Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"641593","DOI":"10.3389\/fneur.2021.641593","article-title":"Comparison of drug availability in the inner ear after oral, transtympanic, and combined administration","volume":"12","author":"Li","year":"2021","journal-title":"Front Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fncel.2019.00418","article-title":"Local delivery of therapeutics to the inner ear: the state of the science","volume":"13","author":"Anderson","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fncel.2020.00226","article-title":"Antioxidants and vasodilators for the treatment of noise-induced hearing loss: are they really effective?","volume":"14","author":"Alvarado","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e12217","DOI":"10.1002\/1348-9585.12217","article-title":"Protective effects of vitamins\/antioxidants on occupational noise-induced hearing loss: a systematic review","volume":"63","author":"Abbasi","year":"2021","journal-title":"J Occup Health."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1089\/ars.2017.7284","article-title":"redox signaling mechanisms in nervous system development","volume":"28","author":"Olguin-Albuerne","year":"2018","journal-title":"Antioxid Redox Signal."},{"key":"B33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fncel.2019.00300","article-title":"Local drug delivery for prevention of hearing loss","volume":"13","author":"Rybak","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.heares.2012.10.011","article-title":"Intra-tympanic delivery of short interfering RNA into the adult mouse cochlea","volume":"296","author":"Oishi","year":"2013","journal-title":"Hear Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1097\/MAO.0000000000002305","article-title":"Poly-lactic acid-based biopolymer formulations are safe for sustained intratympanic dexamethasone delivery","volume":"40","author":"Rousset","year":"2019","journal-title":"Otol Neurotol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"107912","DOI":"10.1016\/j.heares.2020.107912","article-title":"Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear","volume":"394","author":"Akil","year":"2020","journal-title":"Hear Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"107927","DOI":"10.1016\/j.heares.2020.107927","article-title":"Viral vectors for gene delivery to the inner ear","volume":"394","author":"Maguire","year":"2020","journal-title":"Hear Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10544-018-0287-3","article-title":"In-vitro perforation of the round window membrane via direct 3-D printed microneedles","volume":"20","author":"Aksit","year":"2018","journal-title":"Biomed Microdevices."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA vs. miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol Ther Nucleic Acids."},{"key":"B40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.omtn.2018.12.004","article-title":"Optimizing synthetic miRNA minigene architecture for efficient mirna hairpin concatenation and multi-target gene knockdown","volume":"14","author":"Rousset","year":"2019","journal-title":"Mol Ther Nucleic Acids."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.993017\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T05:55:28Z","timestamp":1663307728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.993017\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":40,"alternative-id":["10.3389\/fneur.2022.993017"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.993017","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"993017"}}